Multiple myeloma in remission is a hematological malignancy characterized by the proliferation of monoclonal plasma cells in the bone marrow. The condition is significant as it can lead to various complications, including bone lesions, renal impairment, and immune dysfunction. Accurate coding with ICD-10 Code C90.01 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C90.01 represents Multiple myeloma in remission, indicating a state where the disease is not actively causing symptoms or complications. This code is used when documenting patients who have undergone treatment and are currently free from disease activity, allowing for accurate clinical documentation and billing in healthcare settings.
Multiple myeloma in remission occurs when the malignant plasma cells are no longer detectable, and the patient exhibits no symptoms related to the disease. This condition requires ongoing medical attention to monitor for potential relapse and manage any residual effects of prior treatments.
ICD-10 Code C90.01 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a crucial role in both acute and chronic care settings, ensuring that healthcare providers accurately capture the patient's health status and treatment progress.
In SOAP notes, ICD-10 Code C90.01 connects subjective reports of patient well-being with objective clinical findings, confirming the diagnosis of remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
While patients with Multiple myeloma in remission may not require active treatment, ongoing monitoring and supportive care are essential to maintain health and prevent complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C90.01 is crucial in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, low complexity. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
Common Questions About Using ICD-10 Code C90.01 for Multiple myeloma in remission
What does it mean for multiple myeloma to be in remission?
Remission in multiple myeloma indicates that the disease is not currently active, with no detectable symptoms or signs of disease progression. Regular monitoring is essential to ensure that the patient remains in remission.
How often should patients with multiple myeloma in remission be monitored?
Patients in remission should typically have follow-up appointments every 3 to 6 months to monitor for any signs of relapse and to assess overall health.
Can patients with multiple myeloma in remission experience complications?
Yes, even in remission, patients may experience complications related to previous treatments or the disease itself, such as bone health issues or renal function changes.
Is treatment necessary for patients with multiple myeloma in remission?
Active treatment is generally not required for patients in remission, but supportive care and monitoring are crucial to maintain health and prevent complications.
Clinical Notes
SOAP notes
DAP notes
AI medical notes